Founded Date: 2017-01-01
Last Funding Type: Series C
Headquarters: Boston, Massachusetts, United States
Investors Number: 14.0
Technology: Anti-infective Drugs
Employee Number: 11-50
Industry: Early Drug Development
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-11-29
Funding Status: Late Stage Venture
Total Funding: 210000000.0